Patterson Companies, Inc. (PDCO)
NASDAQ: PDCO · IEX Real-Time Price · USD
23.92
-0.16 (-0.66%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Patterson Companies Revenue

In the fiscal year ending April 27, 2024, Patterson Companies had annual revenue of $6.57B with 1.50% growth. Revenue in the quarter ending April 27, 2024 was $1.72B with 0.09% year-over-year growth.

Revenue (ttm)
$6.57B
Revenue Growth
+1.50%
P/S Ratio
0.32
Revenue / Employee
$864,246
Employees
7,600
Market Cap
2.10B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 27, 20246.57B96.80M1.50%
Apr 29, 20236.47B-27.93M-0.43%
Apr 30, 20226.50B587.34M9.93%
Apr 24, 20215.91B422.06M7.69%
Apr 25, 20205.49B-84.51M-1.52%
Apr 27, 20195.57B108.84M1.99%
Apr 28, 20185.47B-127.44M-2.28%
Apr 29, 20175.59B206.42M3.83%
Apr 30, 20165.39B1.48B37.74%
Apr 25, 20153.91B325.72M9.09%
Apr 26, 20143.59B-52.07M-1.43%
Apr 27, 20133.64B101.55M2.87%
Apr 28, 20123.54B119.99M3.51%
Apr 30, 20113.42B178.29M5.51%
Apr 24, 20103.24B143.15M4.63%
Apr 25, 20093.09B95.50M3.18%
Apr 26, 20083.00B200.33M7.16%
Apr 28, 20072.80B183.28M7.01%
Apr 29, 20062.62B193.67M8.00%
Apr 30, 20052.42B452.11M22.96%
Apr 24, 20041.97B312.39M18.85%
Apr 26, 20031.66B241.44M17.06%
Apr 27, 20021.42B259.06M22.40%
Apr 28, 20011.16B110.57M10.57%
Apr 29, 20001.05B162.62M18.41%
Apr 24, 1999883.27M105.10M13.51%
Apr 25, 1998778.17M90.27M13.12%
Apr 26, 1997687.90M80.91M13.33%
Apr 27, 1996606.98M74.39M13.97%
Apr 29, 1995532.60M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 3.01B
Privia Health Group 1.69B
CONMED 1.26B
Indivior 1.12B
Myriad Genetics 774.20M
UFP Technologies 407.33M
Protagonist Therapeutics 314.95M
Intellia Therapeutics 52.60M
Revenue Rankings